MediWound (MDWD) to Release Earnings on Tuesday

MediWound (NASDAQ:MDWD) will post its quarterly earnings results before the market opens on Tuesday, November 26th. Analysts expect MediWound to post earnings of ($0.48) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

MediWound Stock Down 2.3 %

NASDAQ MDWD opened at $15.64 on Tuesday. The stock has a market capitalization of $168.76 million, a PE ratio of -7.41 and a beta of 0.83. MediWound has a 12-month low of $8.22 and a 12-month high of $24.00. The company has a 50 day moving average price of $17.31 and a two-hundred day moving average price of $17.47.

Analysts Set New Price Targets

Several equities analysts have commented on MDWD shares. HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of MediWound in a research report on Friday, October 11th. StockNews.com raised MediWound to a “sell” rating in a research note on Monday, August 5th.

About MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.